Literature DB >> 843210

[The stiff-man syndrome. A case report with regard to clinical, electromyographical and pharmacological signs (author's transl)].

M Stöhr, R Heckl.   

Abstract

Our electromyographical findings show no evidence for a spinal or neurogenic origin of muscle stiffness in stiff-man syndrome. It is assumed that the tonic muscle rigidity is induced by abnormal impulses from the brainstem. The measured latencies of electrically induced muscle spasm in the legs are in accordance with this hypothetic site of origin. Muscle stiffness and spasm are decreased by the GABA derivative Baclofen as well as by Clonacepam, which is preferable to Diazepam because of less intense sedation. Spasms are increased by Chlorimipramine which may by used as a provocative test in uncertain cases. These pharmacological influences suggest an imbalance between a gabaminergic inhibitory and a noradrenergic and/or serotoninergic excitatory neuronal system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843210     DOI: 10.1007/BF00345955

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  22 in total

1.  A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion.

Authors:  R T Schmidt; S M Stahl; R Spehlmann
Journal:  Neurology       Date:  1975-07       Impact factor: 9.910

2.  A new and effective drug in the treatment of the stiff-man syndrome: preliminary report.

Authors:  F M HOWARD
Journal:  Proc Staff Meet Mayo Clin       Date:  1963-05-22

3.  [On the stiff-man syndrome. Report on a case and a review of the literature].

Authors:  K HUHNSTOCK; R BROCK; E KUHN
Journal:  Dtsch Med Wochenschr       Date:  1962-07-06       Impact factor: 0.628

4.  [Letter: Endogenic depression].

Authors:  N Matussek
Journal:  Dtsch Med Wochenschr       Date:  1976-06-25       Impact factor: 0.628

5.  The effect of chlordiazepoxide, diazepam and nitrazepam on catecholamine metabolism in regions of the rat brain.

Authors:  K M Taylor; R Laverty
Journal:  Eur J Pharmacol       Date:  1969-12       Impact factor: 4.432

6.  [Overexcitability of the gamma-motor neurons in "stiff-man" syndrome].

Authors:  H G Mertens; K Ricker
Journal:  Klin Wochenschr       Date:  1968-01-01

Review 7.  A critical survey of stiff-man syndrome.

Authors:  E E Gordon; D M Januszko; L Kaufman
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

8.  Intravenous chlorimipramine in the treatment of severe depression.

Authors:  G H Collins
Journal:  Br J Psychiatry       Date:  1970-08       Impact factor: 9.319

9.  Stiff-man syndrome and encephalomyelitis. Report of a case.

Authors:  S Kasperek; S Zebrowski
Journal:  Arch Neurol       Date:  1971-01

10.  Progressive encephalomyelitis with rigidity.

Authors:  A M Whiteley; M Swash; H Urich
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

View more
  5 in total

Review 1.  Stiff man syndrome.

Authors:  H M Meinck
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  The stiff-man syndrome: new pathophysiological aspects from abnormal exteroceptive reflexes and the response to clomipramine, clonidine, and tizanidine.

Authors:  H M Meinck; K Ricker; B Conrad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

3.  Stiff man syndrome: clinical and laboratory findings in eight patients.

Authors:  H M Meinck; K Ricker; P J Hülser; E Schmid; J Peiffer; M Solimena
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

4.  Neuropharmacological investigations in the stiff-man syndrome.

Authors:  H M Meinck; B Conrad
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

Review 5.  Pragmatic Treatment of Stiff Person Spectrum Disorders.

Authors:  Bettina Balint; Hans-Michael Meinck
Journal:  Mov Disord Clin Pract       Date:  2018-07-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.